当前位置:
X-MOL 学术
›
Thorac. Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A novel break site of EML4-ALK report and a rare PRKAR1A-ALK report analyzed by different ALK detection platforms in non-small cell lung cancer patients
Thoracic Cancer ( IF 2.3 ) Pub Date : 2021-09-06 , DOI: 10.1111/1759-7714.14123 Xue Du 1 , Jun Zhang 2 , Hongjun Gao 3 , Yanhong Tai 2
Thoracic Cancer ( IF 2.3 ) Pub Date : 2021-09-06 , DOI: 10.1111/1759-7714.14123 Xue Du 1 , Jun Zhang 2 , Hongjun Gao 3 , Yanhong Tai 2
Affiliation
detection of anaplastic lymphoma receptor tyrosine kinase gene (ALK) rearrangements in patients with non-small-cell lung cancer (NSCLC) has become a routine pathological diagnosis worldwide.
中文翻译:
非小细胞肺癌患者不同ALK检测平台分析的EML4-ALK报告新断裂位点和罕见PRKAR1A-ALK报告
检测非小细胞肺癌(NSCLC)患者间变性淋巴瘤受体酪氨酸激酶基因(ALK)重排已成为世界范围内的常规病理诊断。
更新日期:2021-10-18
中文翻译:
非小细胞肺癌患者不同ALK检测平台分析的EML4-ALK报告新断裂位点和罕见PRKAR1A-ALK报告
检测非小细胞肺癌(NSCLC)患者间变性淋巴瘤受体酪氨酸激酶基因(ALK)重排已成为世界范围内的常规病理诊断。